Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Memantine as an Additive Therapy in Patients With Traumatic Brain Injury

NCT06914310 is registered in ClinicalTrials.gov with Mansoura University as lead sponsor.

NCT NCT06914310
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06914310 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Memantine as an Additive Therapy in Patients With Traumatic Brain Injury
Lead sponsor
Mansoura University
Phase
Phase 2/3
Overall status
Not yet recruiting
Start date
March 25, 2025
Completion date
November 30, 2025
Enrollment
80 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

mild traumatic brain injury, moderate traumatic brain injury (tbi)